Skip to content

A multicenter randomized controlled clinical study of CO2 laser treatment and frontolateral laryngectomy in the treatment of (T2N0M0) glottic carcinoma with involvment of anterior commissure

A multicenter randomized controlled clinical study of CO2 laser treatment and frontolateral laryngectomy in the treatment of (T2N0M0) glottic carcinoma with involvment of anterior commissure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012548
Enrollment
Unknown
Registered
2017-09-02
Start date
2017-09-12
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal cancer

Interventions

Group of CO2 laser:Tumor resection by CO2 laser
Group of frontolateral partial resection:Tumor resection by open surgery

Sponsors

The First Affiliated Hospial, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed patients, patients who had not received surgery or radiotherapy before the clinical trial; 2. Pathological diagnosis of laryngeal squamous cell carcinoma (including a variety of differentiation degree); 3. Glottic carcinoma, invasion of anterior commissure, without invasion of thyroid cartilage, no lymph metastasis, clinical stage T2N0M0 (2002 AJCC laryngeal carcinoma TNM stage); 4. Aged from 18 to 75 years; 5. Be in good common condition KPS>=70; 6. The patients have signed the informed consent paper.

Exclusion criteria

Exclusion criteria: 1. CO2 laser group, unable to open mouth, severe cervical spondylosis, ankylosing spondylitis, etc., estimated difficult to expose the surgical area; 2. While suffering from other uncontrolled serious diseases such as tuberculosis, leprosy, and so on; 3. With heart, brain, lung and other vital organs dysfunction.

Design outcomes

Primary

MeasureTime frame
Progress Free Survival;

Secondary

MeasureTime frame
Overall survival time;Non-locoregional recurrence time;Non-metastase time;Short-term curative efficacy;Postsurgical Health-Related Quality;

Countries

China

Contacts

Public ContactLei Wenbin

The First Affiliated Hospial, Sun Yat-Sen University

leiwb@mail.sysu.edu.cn+86 139 2211 3299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026